カテゴリー： Market Monitor Global, 世界, 医療/バイオ

免疫学的製剤の世界市場見通し2023年-2029年

◆英語タイトル：Immunological Agents Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8341 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：112 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Immunological Agents Market 調査レポートは次の情報を含め、グローバルにおけるの免疫学的製剤市場規模と予測を収録しています。・世界の免疫学的製剤市場：売上、2018年-2023年、2024年-2029年
・世界の免疫学的製剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の免疫学的製剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗リウマチ薬（DMARD）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

免疫学的製剤のグローバル主要企業は、Abbott、 Organon、 Pfizer、 Sandoz、 Amneal Pharmaceuticals、 Apotex、 Teva Pharmaceuticals、 Biocon、 Bristol Myers Squibb、 Merck、 CSL Behring、 Sanofi、 Leading Pharma、 Accord Healthcare Inc、 Amgen、 Nabi Biopharmaceuticals、 Ascend Laboratories、 Camber Pharmaceuticals Inc、 Grifols USA、 JOM Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、免疫学的製剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の免疫学的製剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の免疫学的製剤市場：タイプ別市場シェア、2022年
・抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他

世界の免疫学的製剤市場：用途別、2018年-2023年、2024年-2029年
世界の免疫学的製剤市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の免疫学的製剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の免疫学的製剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における免疫学的製剤のグローバル売上、2018年-2023年
・主要企業における免疫学的製剤のグローバル売上シェア、2022年
・主要企業における免疫学的製剤のグローバル販売量、2018年-2023年
・主要企業における免疫学的製剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Abbott、 Organon、 Pfizer、 Sandoz、 Amneal Pharmaceuticals、 Apotex、 Teva Pharmaceuticals、 Biocon、 Bristol Myers Squibb、 Merck、 CSL Behring、 Sanofi、 Leading Pharma、 Accord Healthcare Inc、 Amgen、 Nabi Biopharmaceuticals、 Ascend Laboratories、 Camber Pharmaceuticals Inc、 Grifols USA、 JOM Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
免疫学的製剤市場の定義
市場セグメント
世界の免疫学的製剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の免疫学的製剤市場規模
世界の免疫学的製剤市場規模：2022年 VS 2029年
世界の免疫学的製剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの免疫学的製剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の免疫学的製剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗リウマチ薬（DMARD）、免疫グロブリン、免疫調節剤、免疫抑制剤、モノクローナル抗体、その他
免疫学的製剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
免疫学的製剤の用途別グローバル売上・予測

・地域別市場分析
地域別免疫学的製剤市場規模 2022年と2029年
地域別免疫学的製剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott、 Organon、 Pfizer、 Sandoz、 Amneal Pharmaceuticals、 Apotex、 Teva Pharmaceuticals、 Biocon、 Bristol Myers Squibb、 Merck、 CSL Behring、 Sanofi、 Leading Pharma、 Accord Healthcare Inc、 Amgen、 Nabi Biopharmaceuticals、 Ascend Laboratories、 Camber Pharmaceuticals Inc、 Grifols USA、 JOM Pharmaceuticals
...

This report aims to provide a comprehensive presentation of the global market for Immunological Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunological Agents. This report contains market size and forecasts of Immunological Agents in global, including the following market information:
Global Immunological Agents Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunological Agents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antirheumatic Drugs (DMARDs) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immunological Agents include Abbott, Organon, Pfizer, Sandoz, Amneal Pharmaceuticals, Apotex, Teva Pharmaceuticals, Biocon and Bristol Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunological Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunological Agents Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunological Agents Market Segment Percentages, by Type, 2022 (%)
Antirheumatic Drugs (DMARDs)
Immune Globulins
Immunomodulatory Agents
Immunosuppressive Agents
Monoclonal Antibodies
Other
Global Immunological Agents Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunological Agents Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Others
Global Immunological Agents Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunological Agents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunological Agents revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunological Agents revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Organon
Pfizer
Sandoz
Amneal Pharmaceuticals
Apotex
Teva Pharmaceuticals
Biocon
Bristol Myers Squibb
Merck
CSL Behring
Sanofi
Leading Pharma
Accord Healthcare Inc
Amgen
Nabi Biopharmaceuticals
Ascend Laboratories
Camber Pharmaceuticals Inc
Grifols USA
JOM Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunological Agents, market overview.
Chapter 2: Global Immunological Agents market size in revenue.
Chapter 3: Detailed analysis of Immunological Agents company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunological Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Immunological Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunological Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunological Agents Overall Market Size
2.1 Global Immunological Agents Market Size: 2022 VS 2029
2.2 Global Immunological Agents Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunological Agents Players in Global Market
3.2 Top Global Immunological Agents Companies Ranked by Revenue
3.3 Global Immunological Agents Revenue by Companies
3.4 Top 3 and Top 5 Immunological Agents Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunological Agents Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunological Agents Players in Global Market
3.6.1 List of Global Tier 1 Immunological Agents Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunological Agents Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Immunological Agents Market Size Markets, 2022 & 2029
4.1.2 Antirheumatic Drugs (DMARDs)
4.1.3 Immune Globulins
4.1.4 Immunomodulatory Agents
4.1.5 Immunosuppressive Agents
4.1.6 Monoclonal Antibodies
4.1.7 Other
4.2 By Type – Global Immunological Agents Revenue & Forecasts
4.2.1 By Type – Global Immunological Agents Revenue, 2018-2023
4.2.2 By Type – Global Immunological Agents Revenue, 2024-2029
4.2.3 By Type – Global Immunological Agents Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Immunological Agents Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Immunological Agents Revenue & Forecasts
5.2.1 By Application – Global Immunological Agents Revenue, 2018-2023
5.2.2 By Application – Global Immunological Agents Revenue, 2024-2029
5.2.3 By Application – Global Immunological Agents Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Immunological Agents Market Size, 2022 & 2029
6.2 By Region – Global Immunological Agents Revenue & Forecasts
6.2.1 By Region – Global Immunological Agents Revenue, 2018-2023
6.2.2 By Region – Global Immunological Agents Revenue, 2024-2029
6.2.3 By Region – Global Immunological Agents Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Immunological Agents Revenue, 2018-2029
6.3.2 US Immunological Agents Market Size, 2018-2029
6.3.3 Canada Immunological Agents Market Size, 2018-2029
6.3.4 Mexico Immunological Agents Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Immunological Agents Revenue, 2018-2029
6.4.2 Germany Immunological Agents Market Size, 2018-2029
6.4.3 France Immunological Agents Market Size, 2018-2029
6.4.4 U.K. Immunological Agents Market Size, 2018-2029
6.4.5 Italy Immunological Agents Market Size, 2018-2029
6.4.6 Russia Immunological Agents Market Size, 2018-2029
6.4.7 Nordic Countries Immunological Agents Market Size, 2018-2029
6.4.8 Benelux Immunological Agents Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Immunological Agents Revenue, 2018-2029
6.5.2 China Immunological Agents Market Size, 2018-2029
6.5.3 Japan Immunological Agents Market Size, 2018-2029
6.5.4 South Korea Immunological Agents Market Size, 2018-2029
6.5.5 Southeast Asia Immunological Agents Market Size, 2018-2029
6.5.6 India Immunological Agents Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Immunological Agents Revenue, 2018-2029
6.6.2 Brazil Immunological Agents Market Size, 2018-2029
6.6.3 Argentina Immunological Agents Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Immunological Agents Revenue, 2018-2029
6.7.2 Turkey Immunological Agents Market Size, 2018-2029
6.7.3 Israel Immunological Agents Market Size, 2018-2029
6.7.4 Saudi Arabia Immunological Agents Market Size, 2018-2029
6.7.5 UAE Immunological Agents Market Size, 2018-2029
7 Immunological Agents Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Immunological Agents Major Product Offerings
7.1.4 Abbott Immunological Agents Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Organon
7.2.1 Organon Company Summary
7.2.2 Organon Business Overview
7.2.3 Organon Immunological Agents Major Product Offerings
7.2.4 Organon Immunological Agents Revenue in Global Market (2018-2023)
7.2.5 Organon Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Immunological Agents Major Product Offerings
7.3.4 Pfizer Immunological Agents Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Sandoz
7.4.1 Sandoz Company Summary
7.4.2 Sandoz Business Overview
7.4.3 Sandoz Immunological Agents Major Product Offerings
7.4.4 Sandoz Immunological Agents Revenue in Global Market (2018-2023)
7.4.5 Sandoz Key News & Latest Developments
7.5 Amneal Pharmaceuticals
7.5.1 Amneal Pharmaceuticals Company Summary
7.5.2 Amneal Pharmaceuticals Business Overview
7.5.3 Amneal Pharmaceuticals Immunological Agents Major Product Offerings
7.5.4 Amneal Pharmaceuticals Immunological Agents Revenue in Global Market (2018-2023)
7.5.5 Amneal Pharmaceuticals Key News & Latest Developments
7.6 Apotex
7.6.1 Apotex Company Summary
7.6.2 Apotex Business Overview
7.6.3 Apotex Immunological Agents Major Product Offerings
7.6.4 Apotex Immunological Agents Revenue in Global Market (2018-2023)
7.6.5 Apotex Key News & Latest Developments
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Company Summary
7.7.2 Teva Pharmaceuticals Business Overview
7.7.3 Teva Pharmaceuticals Immunological Agents Major Product Offerings
7.7.4 Teva Pharmaceuticals Immunological Agents Revenue in Global Market (2018-2023)
7.7.5 Teva Pharmaceuticals Key News & Latest Developments
7.8 Biocon
7.8.1 Biocon Company Summary
7.8.2 Biocon Business Overview
7.8.3 Biocon Immunological Agents Major Product Offerings
7.8.4 Biocon Immunological Agents Revenue in Global Market (2018-2023)
7.8.5 Biocon Key News & Latest Developments
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Company Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Immunological Agents Major Product Offerings
7.9.4 Bristol Myers Squibb Immunological Agents Revenue in Global Market (2018-2023)
7.9.5 Bristol Myers Squibb Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Immunological Agents Major Product Offerings
7.10.4 Merck Immunological Agents Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 CSL Behring
7.11.1 CSL Behring Company Summary
7.11.2 CSL Behring Business Overview
7.11.3 CSL Behring Immunological Agents Major Product Offerings
7.11.4 CSL Behring Immunological Agents Revenue in Global Market (2018-2023)
7.11.5 CSL Behring Key News & Latest Developments
7.12 Sanofi
7.12.1 Sanofi Company Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Immunological Agents Major Product Offerings
7.12.4 Sanofi Immunological Agents Revenue in Global Market (2018-2023)
7.12.5 Sanofi Key News & Latest Developments
7.13 Leading Pharma
7.13.1 Leading Pharma Company Summary
7.13.2 Leading Pharma Business Overview
7.13.3 Leading Pharma Immunological Agents Major Product Offerings
7.13.4 Leading Pharma Immunological Agents Revenue in Global Market (2018-2023)
7.13.5 Leading Pharma Key News & Latest Developments
7.14 Accord Healthcare Inc
7.14.1 Accord Healthcare Inc Company Summary
7.14.2 Accord Healthcare Inc Business Overview
7.14.3 Accord Healthcare Inc Immunological Agents Major Product Offerings
7.14.4 Accord Healthcare Inc Immunological Agents Revenue in Global Market (2018-2023)
7.14.5 Accord Healthcare Inc Key News & Latest Developments
7.15 Amgen
7.15.1 Amgen Company Summary
7.15.2 Amgen Business Overview
7.15.3 Amgen Immunological Agents Major Product Offerings
7.15.4 Amgen Immunological Agents Revenue in Global Market (2018-2023)
7.15.5 Amgen Key News & Latest Developments
7.16 Nabi Biopharmaceuticals
7.16.1 Nabi Biopharmaceuticals Company Summary
7.16.2 Nabi Biopharmaceuticals Business Overview
7.16.3 Nabi Biopharmaceuticals Immunological Agents Major Product Offerings
7.16.4 Nabi Biopharmaceuticals Immunological Agents Revenue in Global Market (2018-2023)
7.16.5 Nabi Biopharmaceuticals Key News & Latest Developments
7.17 Ascend Laboratories
7.17.1 Ascend Laboratories Company Summary
7.17.2 Ascend Laboratories Business Overview
7.17.3 Ascend Laboratories Immunological Agents Major Product Offerings
7.17.4 Ascend Laboratories Immunological Agents Revenue in Global Market (2018-2023)
7.17.5 Ascend Laboratories Key News & Latest Developments
7.18 Camber Pharmaceuticals Inc
7.18.1 Camber Pharmaceuticals Inc Company Summary
7.18.2 Camber Pharmaceuticals Inc Business Overview
7.18.3 Camber Pharmaceuticals Inc Immunological Agents Major Product Offerings
7.18.4 Camber Pharmaceuticals Inc Immunological Agents Revenue in Global Market (2018-2023)
7.18.5 Camber Pharmaceuticals Inc Key News & Latest Developments
7.19 Grifols USA
7.19.1 Grifols USA Company Summary
7.19.2 Grifols USA Business Overview
7.19.3 Grifols USA Immunological Agents Major Product Offerings
7.19.4 Grifols USA Immunological Agents Revenue in Global Market (2018-2023)
7.19.5 Grifols USA Key News & Latest Developments
7.20 JOM Pharmaceuticals
7.20.1 JOM Pharmaceuticals Company Summary
7.20.2 JOM Pharmaceuticals Business Overview
7.20.3 JOM Pharmaceuticals Immunological Agents Major Product Offerings
7.20.4 JOM Pharmaceuticals Immunological Agents Revenue in Global Market (2018-2023)
7.20.5 JOM Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Immunological Agents Market Opportunities & Trends in Global Market
Table 2. Immunological Agents Market Drivers in Global Market
Table 3. Immunological Agents Market Restraints in Global Market
Table 4. Key Players of Immunological Agents in Global Market
Table 5. Top Immunological Agents Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immunological Agents Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immunological Agents Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immunological Agents Product Type
Table 9. List of Global Tier 1 Immunological Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunological Agents Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Immunological Agents Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Immunological Agents Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immunological Agents Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Immunological Agents Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Immunological Agents Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immunological Agents Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Immunological Agents Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Immunological Agents Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immunological Agents Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Immunological Agents Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immunological Agents Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Immunological Agents Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immunological Agents Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Immunological Agents Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immunological Agents Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Immunological Agents Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immunological Agents Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Immunological Agents Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immunological Agents Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Company Summary
Table 31. Abbott Immunological Agents Product Offerings
Table 32. Abbott Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Organon Company Summary
Table 35. Organon Immunological Agents Product Offerings
Table 36. Organon Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 37. Organon Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Immunological Agents Product Offerings
Table 40. Pfizer Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Sandoz Company Summary
Table 43. Sandoz Immunological Agents Product Offerings
Table 44. Sandoz Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 45. Sandoz Key News & Latest Developments
Table 46. Amneal Pharmaceuticals Company Summary
Table 47. Amneal Pharmaceuticals Immunological Agents Product Offerings
Table 48. Amneal Pharmaceuticals Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 49. Amneal Pharmaceuticals Key News & Latest Developments
Table 50. Apotex Company Summary
Table 51. Apotex Immunological Agents Product Offerings
Table 52. Apotex Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 53. Apotex Key News & Latest Developments
Table 54. Teva Pharmaceuticals Company Summary
Table 55. Teva Pharmaceuticals Immunological Agents Product Offerings
Table 56. Teva Pharmaceuticals Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 57. Teva Pharmaceuticals Key News & Latest Developments
Table 58. Biocon Company Summary
Table 59. Biocon Immunological Agents Product Offerings
Table 60. Biocon Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 61. Biocon Key News & Latest Developments
Table 62. Bristol Myers Squibb Company Summary
Table 63. Bristol Myers Squibb Immunological Agents Product Offerings
Table 64. Bristol Myers Squibb Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol Myers Squibb Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Immunological Agents Product Offerings
Table 68. Merck Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. CSL Behring Company Summary
Table 71. CSL Behring Immunological Agents Product Offerings
Table 72. CSL Behring Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 73. CSL Behring Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Immunological Agents Product Offerings
Table 76. Sanofi Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Leading Pharma Company Summary
Table 79. Leading Pharma Immunological Agents Product Offerings
Table 80. Leading Pharma Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 81. Leading Pharma Key News & Latest Developments
Table 82. Accord Healthcare Inc Company Summary
Table 83. Accord Healthcare Inc Immunological Agents Product Offerings
Table 84. Accord Healthcare Inc Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 85. Accord Healthcare Inc Key News & Latest Developments
Table 86. Amgen Company Summary
Table 87. Amgen Immunological Agents Product Offerings
Table 88. Amgen Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 89. Amgen Key News & Latest Developments
Table 90. Nabi Biopharmaceuticals Company Summary
Table 91. Nabi Biopharmaceuticals Immunological Agents Product Offerings
Table 92. Nabi Biopharmaceuticals Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 93. Nabi Biopharmaceuticals Key News & Latest Developments
Table 94. Ascend Laboratories Company Summary
Table 95. Ascend Laboratories Immunological Agents Product Offerings
Table 96. Ascend Laboratories Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 97. Ascend Laboratories Key News & Latest Developments
Table 98. Camber Pharmaceuticals Inc Company Summary
Table 99. Camber Pharmaceuticals Inc Immunological Agents Product Offerings
Table 100. Camber Pharmaceuticals Inc Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 101. Camber Pharmaceuticals Inc Key News & Latest Developments
Table 102. Grifols USA Company Summary
Table 103. Grifols USA Immunological Agents Product Offerings
Table 104. Grifols USA Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 105. Grifols USA Key News & Latest Developments
Table 106. JOM Pharmaceuticals Company Summary
Table 107. JOM Pharmaceuticals Immunological Agents Product Offerings
Table 108. JOM Pharmaceuticals Immunological Agents Revenue (US$, Mn) & (2018-2023)
Table 109. JOM Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Immunological Agents Segment by Type in 2022
Figure 2. Immunological Agents Segment by Application in 2022
Figure 3. Global Immunological Agents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immunological Agents Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immunological Agents Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunological Agents Revenue in 2022
Figure 8. By Type - Global Immunological Agents Revenue Market Share, 2018-2029
Figure 9. By Application - Global Immunological Agents Revenue Market Share, 2018-2029
Figure 10. By Type - Global Immunological Agents Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Immunological Agents Revenue Market Share, 2018-2029
Figure 12. By Application - Global Immunological Agents Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Immunological Agents Revenue Market Share, 2018-2029
Figure 14. By Region - Global Immunological Agents Revenue Market Share, 2018-2029
Figure 15. By Country - North America Immunological Agents Revenue Market Share, 2018-2029
Figure 16. US Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Immunological Agents Revenue Market Share, 2018-2029
Figure 20. Germany Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 21. France Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Immunological Agents Revenue Market Share, 2018-2029
Figure 28. China Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 32. India Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Immunological Agents Revenue Market Share, 2018-2029
Figure 34. Brazil Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Immunological Agents Revenue Market Share, 2018-2029
Figure 37. Turkey Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Immunological Agents Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Organon Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sandoz Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amneal Pharmaceuticals Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Apotex Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Teva Pharmaceuticals Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Biocon Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol Myers Squibb Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. CSL Behring Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Leading Pharma Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Accord Healthcare Inc Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Amgen Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Nabi Biopharmaceuticals Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Ascend Laboratories Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Camber Pharmaceuticals Inc Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Grifols USA Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. JOM Pharmaceuticals Immunological Agents Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 免疫学的製剤の世界市場見通し2023年-2029年(Immunological Agents Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

免疫学的製剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp